Tirzepatide
Tirzepatide | 10mg & 20mg
For Research Use Only — Not for Human Consumption
Tirzepatide is a synthetic research peptide characterized for its activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These incretin receptor systems are studied in laboratory research involving metabolic signaling, glucose-dependent cellular responses, energy regulation, and nutrient-associated signaling pathways.
Product Specifications
Product Name: Tirzepatide
Available Sizes: 10mg / 20mg
Form: Lyophilized Powder
Packaging: Sealed Research Vial
Research Classification: Dual GIP / GLP-1 Receptor Agonist
Intended Use: Laboratory Research Only
Available Variants
10mg Vial: Contains a labeled quantity of 10mg of lyophilized tirzepatide research peptide.
20mg Vial: Contains a labeled quantity of 20mg of lyophilized tirzepatide research peptide.
Research Applications
Tirzepatide is studied in controlled research models examining:
-
GIP receptor signaling
-
GLP-1 receptor signaling
-
Dual incretin pathway activity
-
Metabolic signaling
-
Glucose-dependent cellular responses
-
Energy homeostasis and nutrient-related signaling
Research Use Disclaimer
For laboratory research use only. Not intended for human or animal consumption, clinical use, diagnostic use, or therapeutic applications.
-
Estimated Delivery:Nov 21 - Nov 25
TECHNICAL SPECIFICATIONS +